Meridian Bioscience Inc (VIVO) Inventory Turnover Ratio, from first quarter 2023 to first quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Meridian Bioscience Inc   (NASDAQ: VIVO)
 

Meridian Bioscience Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2023, Meridian Bioscience Inc 's inventory turnover ratio sequentially decreased to 1.86 in the first quarter 2022, otherwise the ratio remained above the average, as VIVO's markets remain strong.Meridian Bioscience Inc 's average inventory processing period in the Dec 31 2022 quarter, has increased to 196 days, from 179 days, in the Sep 30 2022 quarter.

Within Healthcare sector 284 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2023, to 1701, from total ranking in the fourth quarter 2022 at 1807.

VIVO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Meridian Bioscience Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VIVO Inventory Turnover Ratio (Dec 31 2022)
I. Quarter		 (Sep 30 2022)
IV. Quarter		 (Jun 30 2022)
III. Quarter		 (Mar 31 2022)
II. Quarter		 (Dec 31 2021)
I. Quarter
Y / Y Inventory Growth -2.07 % -11.75 % -2.38 % -2.22 % 10.34 %
Y / Y Cost of Sales Growth -35.18 % 0.62 % 17.59 % 55.51 % 24.91 %
Inventory Turnover Ratio (TTM) 1.86 2.04 1.98 1.9 1.69
VIVO's Total Ranking # 1701 # 1807 # 1717 # 1717 # 1543
Average inventory processing period 196 179 184 192 216
Seq. Inventory Growth 7.15 % -3.27 % -1.16 % -4.41 % -3.44 %
Seq. Cost of Sales Growth -19.84 % 2.06 % -27.39 % 9.12 % 24.44 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 13
Healthcare Sector # 285
Overall Market # 1701

Inventory Turnover Ratio Statistics
High Average Low
2.17 1.8 1.36
(Jun 30 2015)   (Sep 30 2011)



VIVO Company Profile >> Back to VIVO Efficiency Comparisons >> Compare VIVO Inventory Turnover Ratio to its Competitors

Financial Statements
Meridian Bioscience Inc 's Inventories $ 73 Millions Visit VIVO's Balance sheet
Meridian Bioscience Inc 's Cost of Revenues TTM $ 131 Millions Visit VIVO's Income Statement
What are VIVO's Sales? Visit VIVO's Sales by Segment

Other Inventory Turnover Ratios
Meridian Bioscience Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VIVO's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VIVO's Competitors
Inventory Turnover Ratio for VIVO's Suppliers
Inventory Turnover Ratio for VIVO's Customers

You may also want to know
VIVO's Sales Growth Rates VIVO's Pe Price to earnings ratio VIVO's Receivables Turnover Ratio VIVO's Stock Quote
VIVO's Net Income Growth Rates VIVO's Ps Price to Sales ratio VIVO's Sales per Employee VIVO's Asset Turnover Ratio
VIVO's Net Margin VIVO's Pb Price to Book ratio VIVO's Financial Strength Ratios VIVO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2022 Inventories at quarter ending Dec 31 2022
Lftd Partners Inc   4.79 $ 33.933  Millions$ 7  Millions
Harrow Inc   4.76 $ 25.383  Millions$ 5  Millions
Henry Schein Inc   4.72 $ 8,816.000  Millions$ 1,869  Millions
Bristol myers Squibb Company  4.68 $ 10,137.000  Millions$ 2,165  Millions
Horizon Therapeutics Public Limited Company  4.66 $ 920.197  Millions$ 198  Millions
Incyte Corporation  4.66 $ 206.997  Millions$ 44  Millions
Catalyst Pharmaceuticals Inc   4.65 $ 34.393  Millions$ 7  Millions
Sanuwave Health Inc   4.64 $ 4.883  Millions$ 1  Millions
Nexgel Inc   4.59 $ 1.792  Millions$ 0  Millions
Catalent Inc   4.54 $ 3,325.300  Millions$ 732  Millions
Precision Optics Corporation Inc   4.42 $ 12.798  Millions$ 3  Millions
Steris Plc  4.41 $ 2,410.613  Millions$ 547  Millions
Organogenesis Holdings Inc   4.40 $ 105.059  Millions$ 24  Millions
Steris Plc  4.37 $ 2,640.436  Millions$ 604  Millions
Invacare Holdings Corporation  4.36 $ 566.340  Millions$ 130  Millions
T2 Biosystems Inc   4.36 $ 21.101  Millions$ 5  Millions
Logicmark Inc  4.34 $ 4.686  Millions$ 1  Millions
Alimera Sciences Inc  4.25 $ 7.977  Millions$ 2  Millions
West Pharmaceutical Services Inc   4.23 $ 1,750.700  Millions$ 414  Millions
Integrated Biopharma Inc  4.17 $ 48.036  Millions$ 12  Millions
Teva Pharmaceutical Industries Limited  4.16 $ 7,952.000  Millions$ 1,912  Millions
Myomo Inc   4.10 $ 5.302  Millions$ 1  Millions
Rayont Inc   4.08 $ 1.868  Millions$ 0  Millions
Eargo Inc   4.07 $ 22.988  Millions$ 6  Millions
Tandem Diabetes Care Inc   4.04 $ 388.231  Millions$ 96  Millions
Idexx Laboratories Inc  4.02 $ 1,365.078  Millions$ 339  Millions
Qiagen N v   4.01 $ 702.046  Millions$ 175  Millions
Novocure Limited  4.00 $ 114.867  Millions$ 29  Millions
Enzo Biochem Inc  3.99 $ 61.743  Millions$ 15  Millions
Evolus Inc   3.97 $ 55.887  Millions$ 14  Millions

Date modified: 2026-09-08T15:10:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.